Alterations in Serum Levels of Trace Element in Patients with Breast Cancer Before and After Chemotherapy

Overview

Journal Caspian J Intern Med

Specialty General Medicine

Date 2018 May 8

PMID 29732030

Citations 8

Authors

Norjis Ahmadi

Soleiman Mahjoub

Reza Haji Hosseini

Mostafa TaherKhani

Dariush Moslemi

Affiliations

Soon will be listed here.

Abstract

Background: Breast cancer is the most common serious disease around the world. The trace elements have a vital role in the metabolism and chemotherapy may change the level of metal ions. Due to the ambiguity of the existence in this regard, the study examined the trace element serum levels in women with breast cancer before and after chemotherapy .

Methods: Sixty patients were studied undergoing specialist. First sampling was taken before chemotherapy (after 4 weeks of surgery) and second sampling was taken after the completion of 3 courses of chemotherapy, approximately 9 weeks after the first chemotherapy. The patients took Adriamycin 60mg/m Cytoxan 600mg/m. Serum zinc and iron levels were measured using standard spectrophotometric method. Measurement of serum copper was done by atomic absorption spectroscopy

Results: Serum zinc and iron levels in women after chemotherapy significantly decreased (p<0.001), however, the serum level of copper increased but was not significant (P=0.676).

Conclusions: Our findings demonstrate significant decrease in zinc and iron levels in breast cancer patients after 3 courses of Adriamycin and Cytoxan chemotherapy. Prescribing zinc supplements can be useful after chemotherapy.

Citing Articles

The crosstalk between copper-induced oxidative stress and cuproptosis: a novel potential anticancer paradigm.

Vo T, Peng T, Nguyen T, Bui T, Wang C, Lee W Cell Commun Signal. 2024; 22(1):353.

PMID: 38970072 PMC: 11225285. DOI: 10.1186/s12964-024-01726-3.

Long-term adjuvant administration of temozolomide impacts serum ions concentration in high-grade glioma.

Zhong L, Yang P, Zhang C, Wang Z, Jiang T, Chen B Chin Neurosurg J. 2022; 8(1):6.

PMID: 35216639 PMC: 8876447. DOI: 10.1186/s41016-022-00271-7.

Cancer Influences the Elemental Composition of the Myocardium More Strongly than Conjugated Linoleic Acids-Chemometric Approach to Cardio-Oncological Studies.

Bialek A, Bialek M, Lepionka T, Ruszczynska A, Bulska E, Czauderna M Molecules. 2021; 26(23).

PMID: 34885709 PMC: 8659207. DOI: 10.3390/molecules26237127.

Pre-Clinical Insights into the Iron and Breast Cancer Hypothesis.

Thompson H, Neil E, McGinley J Biomedicines. 2021; 9(11).

PMID: 34829880 PMC: 8615831. DOI: 10.3390/biomedicines9111652.

Modulation of Intracellular Copper Levels as the Mechanism of Action of Anticancer Copper Complexes: Clinical Relevance.

Babak M, Ahn D Biomedicines. 2021; 9(8).

PMID: 34440056 PMC: 8389626. DOI: 10.3390/biomedicines9080852.

References

Faber M, Coudray C, Hida H, Mousseau M, Favier A . Lipid peroxidation products, and vitamin and trace element status in patients with cancer before and after chemotherapy, including adriamycin. A preliminary study. Biol Trace Elem Res. 1995; 47(1-3):117-23. DOI: 10.1007/BF02790108. View

McCall K, Huang C, Fierke C . Function and mechanism of zinc metalloenzymes. J Nutr. 2000; 130(5S Suppl):1437S-46S. DOI: 10.1093/jn/130.5.1437S. View

Jezierska-Drutel A, Rosenzweig S, Neumann C . Role of oxidative stress and the microenvironment in breast cancer development and progression. Adv Cancer Res. 2013; 119:107-25. PMC: 3950899. DOI: 10.1016/B978-0-12-407190-2.00003-4. View

Mulware S . Trace elements and carcinogenicity: a subject in review. 3 Biotech. 2017; 3(2):85-96. PMC: 3597132. DOI: 10.1007/s13205-012-0072-6. View

Khan N, Afaq F, Mukhtar H . Lifestyle as risk factor for cancer: Evidence from human studies. Cancer Lett. 2010; 293(2):133-43. PMC: 2991099. DOI: 10.1016/j.canlet.2009.12.013. View

Nicolini A, Mancini P, Ferrari P, Anselmi L, Tartarelli G, Bonazzi V . Oral low-dose cyclophosphamide in metastatic hormone refractory prostate cancer (MHRPC). Biomed Pharmacother. 2004; 58(8):447-50. DOI: 10.1016/j.biopha.2004.08.006. View

Zacharski L, Chow B, Howes P, Shamayeva G, Baron J, Dalman R . Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J Natl Cancer Inst. 2008; 100(14):996-1002. DOI: 10.1093/jnci/djn209. View

Khosravi Shahi P, Izarzugaza Peron Y, Encinas Garcia S, Diaz Munoz de la Espada V, Perez Manga G . [Adjuvant treatment of operable breast cancer]. An Med Interna. 2008; 25(1):36-40. DOI: 10.4321/s0212-71992008000100010. View

Ziech D, Franco R, Georgakilas A, Georgakila S, Malamou-Mitsi V, Schoneveld O . The role of reactive oxygen species and oxidative stress in environmental carcinogenesis and biomarker development. Chem Biol Interact. 2010; 188(2):334-9. DOI: 10.1016/j.cbi.2010.07.010. View

10.

Kremer L, van Dalen E, Offringa M, Ottenkamp J, VOUTE P . Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study. J Clin Oncol. 2001; 19(1):191-6. DOI: 10.1200/JCO.2001.19.1.191. View

11.

TaherKhani M, Mahjoub S, Moslemi D, Karkhah A . Three cycles of AC chemotherapy regimen increased oxidative stress in breast cancer patients: A clinical hint. Caspian J Intern Med. 2017; 8(4):264-268. PMC: 5686304. DOI: 10.22088/cjim.8.4.264. View

12.

Sadjadi A, Nouraie M, Ghorbani A, Alimohammadian M, Malekzadeh R . Epidemiology of breast cancer in the Islamic Republic of Iran: first results from a population-based cancer registry. East Mediterr Health J. 2010; 15(6):1426-31. View

13.

Huang Y, Sheu J, Lin T . Association between oxidative stress and changes of trace elements in patients with breast cancer. Clin Biochem. 1999; 32(2):131-6. DOI: 10.1016/s0009-9120(98)00096-4. View

14.

Mazdak H, Yazdekhasti F, Movahedian A, Mirkheshti N, Shafieian M . The comparative study of serum iron, copper, and zinc levels between bladder cancer patients and a control group. Int Urol Nephrol. 2009; 42(1):89-93. DOI: 10.1007/s11255-009-9583-4. View

15.

Valentine J, Doucette P, Potter S . Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu Rev Biochem. 2005; 74:563-93. DOI: 10.1146/annurev.biochem.72.121801.161647. View

16.

Weydert C, Waugh T, Ritchie J, Iyer K, Smith J, Li L . Overexpression of manganese or copper-zinc superoxide dismutase inhibits breast cancer growth. Free Radic Biol Med. 2006; 41(2):226-37. DOI: 10.1016/j.freeradbiomed.2006.03.015. View

17.

Brewer G . Copper control as an antiangiogenic anticancer therapy: lessons from treating Wilson's disease. Exp Biol Med (Maywood). 2001; 226(7):665-73. DOI: 10.1177/153537020222600712. View

18.

Siegel R, Naishadham D, Jemal A . Cancer statistics, 2012. CA Cancer J Clin. 2012; 62(1):10-29. DOI: 10.3322/caac.20138. View

19.

Hassan M, Ansari J, Spooner D, Hussain S . Chemotherapy for breast cancer (Review). Oncol Rep. 2010; 24(5):1121-31. DOI: 10.3892/or_00000963. View

20.

Hayes D . Is there a standard type and duration of adjuvant chemotherapy for early stage breast cancer?. Breast. 2009; 18 Suppl 3:S131-4. DOI: 10.1016/S0960-9776(09)70287-5. View